Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
US Department of Justice
Julphar
Accenture
Mallinckrodt
Cantor Fitzgerald
Cipla
Fish and Richardson
Cerilliant

Generated: April 24, 2018

DrugPatentWatch Database Preview

LIQUAMAR Drug Profile

« Back to Dashboard

When do Liquamar patents expire, and what generic alternatives are available?

Liquamar is a drug marketed by Organon Usa Inc and is included in one NDA.

The generic ingredient in LIQUAMAR is phenprocoumon. Additional details are available on the phenprocoumon profile page.
Drug patent expirations by year for LIQUAMAR
Medical Subject Heading (MeSH) Categories for LIQUAMAR
Synonyms for LIQUAMAR
2-hydroxy-3-(1-phenylpropyl)-4H-chromen-4-one
2-hydroxy-3-(1-phenylpropyl)chromen-4-one
2H-1-Benzopyran-2-one, 4-hydroxy-3-(1-phenylpropyl)-
2H-Pyran-2-one, 4-hydroxy-3-[[2-(1-methylethyl)phenyl]thio]-6-(3-methylphenyl)-
3-(.alpha.-Ethylbenzyl)-4-hydroxycoumarin
3-(1-Phenylpropyl)-4-hydroxycoumarin
3-(1'-Phenyl-propyl)-4-oxycoumarin
3-(1'-Phenyl-propyl)-4-oxycoumarin [German]
3-(a-ethyl-benzyl)-4-hydroxycoumarin
3-(alpha-Ethylbenzyl)-4-hydroxycoumarin
3-(alpha-Phenylpropyl)-4-hydroxycoumarin
4-Hydroxy-3-(1-phenylpropyl)-2H-1-benzopyran-2-one
4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-on
4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one
4-Hydroxy-3-(1-phenylpropyl)-2H-chromen-2-one #
4-hydroxy-3-(1-phenylpropyl)chromen-2-one
435-97-2
4CA-1012
4H-1-Benzopyran-4-one, 2-hydroxy-3-(1-phenylpropyl)-
6018AB
70206-44-9
AB2000540
AC1L1U3E
AK121858
AKOS002126557
AKOS016844146
AKOS030553010
AN-536
API0003816
AX8147516
BDBM768
BRN 1291115
C-23693
CC-33643
CHEBI:50438
CHEMBL16694
Coumarin, 3-(.alpha.-ethylbenzyl)-4-hydroxy-
Coumarin, 3-(alpha-ethylbenzyl)-4-hydroxy-
CTK2H5169
D05457
D0QV5T
DB00946
DQDAYGNAKTZFIW-UHFFFAOYSA-N
DR000964
DTXSID5023459
EINECS 207-108-9
EN300-219939
Falithiom
Falithrom
Falithrom (TN)
Fencumar
Fenprocoumona
Fenprocoumona [INN-Spanish]
fenprocumon
Fenprocumone
Fenprocumone [DCIT]
FT-0698417
GTPL6839
HE153851
HE343308
Hexal Brand of Phenprocoumon
HSDB 3248
J-510448
Liquamar (TN)
LS-55203
Marcoumar
Marcoumar (TN)
Marcoumar;Marcumar and Falithrom;Marcumar
Marcumar
Marcumar (TN)
Marcuphen
MLS006010940
Oprea1_002598
Phenprocoumalol
Phenprocoumarol
Phenprocoumarole
PHENPROCOUMON
Phenprocoumon (Marcumar)
Phenprocoumon (USAN/INN)
Phenprocoumon [USAN:INN:BAN]
Phenprocoumon(Marcumar)
Phenprocoumone
Phenprocoumone [INN-French]
Phenprocoumonum
Phenprocoumonum [INN-Latin]
Phenprocumone
Phenprocumonum
Phenprogramma
Phenylpropylhydroxycumarinum
QC-2004
RL03668
Ro 1-4849
Roche Brand of Phenprocoumon
S-7748
SC-52062
SCHEMBL1651720
SCHEMBL43031
SMR004703040
U29342
Worwag Brand of Phenprocoumon
Z2186911943

US Patents and Regulatory Information for LIQUAMAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc LIQUAMAR phenprocoumon TABLET;ORAL 011228-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Farmers Insurance
QuintilesIMS
Harvard Business School
Julphar
Queensland Health
Cantor Fitzgerald
Mallinckrodt
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.